US Patent Issued to Nanyang Technological University on May 19 for "Humanized monoclonal antibody against cANGPTL4" (Singaporean Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,621, issued on May 19, was assigned to Nanyang Technological University (Singapore).

"Humanized monoclonal antibody against cANGPTL4" was invented by Nguan Soon Tan (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to humanized antibodies directed against C-terminal Angiopoietin-like 4 protein (cANGPTL4) and uses thereof, such as their use in treating cancer and methods of cancer treatment."

The patent was filed on April 26, 2021, under Application No. 17/997,165.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah...